ALMS vs CRMD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CRMD Captures Institutional Edge (3โ1 Pillars ยท 6โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CorMedix Inc. (CRMD) driven by superior Valuation, Growth & Margin, Momentum & Technical while ALMS counters with relative strength in Options & Structure. Fundamentally, ALMS trades at N/M Forward P/E with -5938.1% operating margin (-7.7% YoY revenue) versus CRMD at 29.5x Forward P/E and 41.0% operating margin (-47.7% YoY). In options structure, ALMS sits in BREAKDOWN (11th %ile IV; Dealer Gamma Walls on Pro) against CRMD sits in BREAKDOWN (90th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ALMS Revenue | CRMD Revenue | ALMS Op. Margin | CRMD Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2017 | N/A | $0M | N/A | -9997.4% | CRMD |
| FY2018 | N/A | $0M | N/A | -6250.4% | CRMD |
| FY2019 | N/A | $0M | N/A | -7416.3% | CRMD |
| FY2020 | N/A | $0M | N/A | -11378.4% | CRMD |
| FY2021 | N/A | $0M | N/A | -15417.5% | CRMD |
| FY2022 | N/A | $0M | N/A | -46819.9% | CRMD |
| FY2024 | N/A | $40M | N/A | -51.4% | CRMD |
| FY2025 | $20M | $310M | -1886.9% | 48.2% | CRMD |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ALMS | CRMD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $727.0M | $370.6M | Larger Scale | ALMS |
| Trailing P/E Ratio Valuation | N/M | 2.4x | Lower Multiple | CRMD |
| Forward P/E Ratio Valuation | N/M | 29.5x | Lower Multiple | CRMD |
| Revenue Growth (YoY) Growth | -7.7% | -47.7% | Higher Growth | ALMS |
| Operating Margin (TTM) Profitability | -5938.1% | 41.0% | Higher Margin | CRMD |
| Net Profit Margin Profitability | 0.0% | 15.5% | Higher Margin | CRMD |
| Return on Equity (ROE) Capital Efficiency | -110.9% | 15.3% | Higher ROE | CRMD |
| 52-Week Range Position Momentum | 1% ($5โ$31) | 0% ($5โ$13) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | 2.25ฮฒ ยท 85% Vol | 1.22ฮฒ ยท 103% Vol | Lower Realized Risk | ALMS |
| Unified Institutional Score Composite Signal | 44.8 / 100 (HOLD) | 55.5 / 100 (HOLD) | Higher Composite | CRMD |